Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00148824Phase 2Completed
Phase 2, randomised trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection (2 arms), sponsored by ANRS. Primary endpoint: Proportion of patients responders to 7 pneumococcal polysaccharides at 8 weeks. Started Feb 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00148824.